Overall, the results of this study clearly demonstrated the potential relevance of the FRα in imaging or treatment not only of high-grade serous EOC, but also of the less prevalent cases such as low-grade serous carcinoma, endometrioid and clear cell carcinomas. This evidence concerns the gene FOLR1 and clear cell adenocarcinoma.